✦ LIBER ✦
PCV16 ROSUVASTATIN IS MORE COST-EFFECTIVE COMPARED TO ATORVASTATIN AND SIMVASTATIN FOR HYPERLIPIDEMIA MANAGEMENT IN HIGH-RISK PATIENTS IN ROUTINE CLINICAL PRACTICE
✍ Scribed by RL Ohsfeldt; SK Gandhi; KM Fox; T Stacy; JM McKenney
- Book ID
- 119595560
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 45 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.